| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $654K | +38.3% |
| Cost of Revenue | $121K | +365.4% |
| R&D Expense | $26.7M | -16.5% |
| SG&A Expense | $14.4M | -14.9% |
| Operating Income | -$40.5M | +16.3% |
| Interest Expense | $4.6M | +38.3% |
| Pre-tax Income | -$49.5M | -65.5% |
| Income Tax | $0 | — |
| Net Income | -$49.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.8M | +57.2% |
| Short-term Investments | $6.2M | +24.0% |
| Accounts Receivable | $143K | -24.3% |
| Inventory | $37K | -14.0% |
| Current Assets | $38.9M | +33.1% |
| Total Assets | $52.3M | +17.6% |
| Current Liabilities | $25.3M | +82.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.2M | +22.7% |
| Capital Expenditures | $330K | -93.6% |
| Investing Cash Flow | -$1.5M | +85.3% |
| Financing Cash Flow | $42.2M | +144.4% |
| Free Cash Flow | -$30.5M | +31.0% |
| -65.5% |
| EPS (Basic) | -$0.47 | -2.2% |
| Total Liabilities |
| $39.0M |
| -5.6% |
| Stockholders' Equity | $13.4M | +313.7% |